Therapeutic & Scientific Innovations
Explore our research and perspectives on therapeutic and scientific innovations.
-
Read Post
Spacer Tile
-
Improving Measurability in Clinical Trials
section -
Read PostHow Calibrated Are Your Trial-Measurement Tools?
-
Read PostLack of Training Compromises Trial Results
-
QuizQuiz: Can You Mitigate Human Error in Your Trial?
-
Read PostMind Map: Building a Framework for Measurement Reliability
-
Addressing Placebo Response
section -
58:43Watch VideoPlacebo Response in Clinical Trials: Approaches to Mitigation
Industry trends show that a major contributor to trial failure is the increased rate of placebo response.Watch this webinar to learn how to increase the chances of trial success in an uncertain world.
-
Read FlipbookAddressing Suggestibility as a Psychological Phenomenon in Clinical Trials
It is important to understand patient perspectives and to anticipate how subjects in research studies may be impacted by the presence of digital tools, devices, and mobile health applications
-
58:13Watch VideoHow Optimized Training Can Lead to a Positive Clinical Trial
-
Read FlipbookClinical Researcher: Myths and Realities of Placebo Response - A 21st Century Prescription
Rates of placebo response across multiple therapeutic areas are now historically high. This article addresses 3 commonly shared ideas that researchers have about placebo response.
-
Driving Success in Study Startup
section -
Read Flipbook
Improving Subject Selection and Endpoint Management in Alzheimer's Trials
-
Read PostPodcast: Important Trends in CNS Clinical Trials in 2019 with guest Christoph Correll, MD
-
Read PostPodcast: Exciting Developments in Psychopharmacology with guest Andrew Cutler, MD
-
Read PostPodcast: The Most Pressing Challenges in Psychiatry Clinical Trials with Leslie Citrome, MD, MPH
-
Read Post4 Recurring Risks to Consider in Early Phase CNS Research
Early phase CNS research is plagued by a higher than average failure rate and complicated by a lack of discreet endpoints. So how can sponsors ameliorate their chances of success from the start?
-
Read FlipbookAre Scientists Closing in on Treatments for Schizophrenia's Most Elusive Symptoms?
Researchers, buoyed by a spike in promising clinical trials and tools, believe they may be close to unraveling new ways to treat some of the most insidious yet elusive effects of schizophrenia
-
Read PostCNS Science Has Outpaced Tool Development; It’s Time to Catch Up
For the first time in decades, we’re developing CNS drugs with new mechanisms of action. Unfortunately, our measurement tools are stuck in the past.
-
Innovations in Pain Treatment
section -
Read FlipbookBridging the Measurement Gap Between Research and Clinical Care in Schizophrenia
The aim of this paper is to discuss how the measurement gap between research and clinical care in schizophrenia can be closed.
-
Precision Medicine & Genetics
section -
Read FlipbookThe Digital Pill
We are experiencing a revolution in healthcare, with powerful medicine and innovative technology coming together to transform the way we treat patients and manage diseases.
-
Read FlipbookQ&A with Dr. Sofija Jovic
Increasingly, sponsors are turning to experts who have “been there, done that” to help them develop protocols for their CNS trials. In this wide-ranging interview, Sofija Jovic, PhD, MBA, of WCG...
-
Read PostPodcast: The Most Pressing Challenges and Opportunities in Pain Research with guest Nathaniel Katz, MD, MS
-
Loading More...
